Peter Cicala's appointment to Eterna's Board is viewed posit...

Peter Cicala's appointment to Eterna's Board is viewed positively due to his extensive biotech and pharma industry experience. His intellectual property expertise and strategic management skills are anticipated to aid in developing next-gen mRNA cell engineering therapies.